Purchase Order 75N93019P00576
Award Date 5/22/19
Potential Completion Date 5/24/20
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21205, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $2M definitive contract to Accelevir Diagnostics LLC of East Case, MD. The contract is for ProViral Sequencing Driven Development of EnHanced IPDAV2 with Global HIV-1 Group M Coverage to Support Worldwide Cure and Clinical Trials. The prime contractor will perform research and development of enhanced diagnostics to support global HIV cure and clinical trials...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, has awarded a $299,968 Small Business Innovation Research (SBIR) Phase I contract to Vitruvian Bio, LLC, a small disadvantaged and woman-owned business. The contract is for the development of an "Electrochemical Self-Monitoring Device for Rapid Nucleic Acid Based Testing of HIV-1". This specialized medical research and diagnostic technology...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, awarded a firm-fixed-price purchase order to Advanced Cell Diagnostics, Inc. (ACD) for $11,115.20. The award, identified as 75N93025P00115, is for the supply of an ACD product, the AMBIS #2249268, which represents ACD's proprietary RNAscope technology and related molecular diagnostics products. This technology enables the visualization and quantification of...
- This federal contract award, valued at $3,820.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Cell Diagnostics, Inc. (ACD), a for-profit manufacturer of molecular diagnostics products. The contract is for the provision of reagents and supplies necessary for performing an assay on the Ventana Discovery Ultra Stainer. This purchase order contract is a firm-fixed-price arrangement with no...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $15,307.50 firm fixed price purchase order to Advanced Cell Diagnostics, Inc., doing business as ACD, a subsidiary of Bio-Techne Corporation doing business as Bio-Techne. The contract is for the delivery of RNASCOPE HIPLEX assay reagents and probes to support research efforts in Newark, California, over a period of three months concluding on October 31,...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Darwin Biosciences, Inc., a minority-owned, woman-owned small business based in Broomfield, Colorado. The $299,408 firm-fixed-price contract is for the development of rapid diagnostic assays to aid in the self-monitoring of acute or rebound HIV-1 infection. The contract has an ultimate completion date of April 14, 2025. As an SBIR Phase I award,...
- This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), a civilian federal agency. The award was made to Personal Diagnostix Inc., a minority-owned, self-certified small disadvantaged business, for the provision of 12 custom PCR assays on viral RNA samples at $120 each, for a total ceiling value of $10,440.00. The contract was issued as a firm fixed price purchase order with a period of...
- The National Institute of Allergy and Infectious Diseases, a civilian agency within the U.S. Department of Health and Human Services, awarded a Firm Fixed Price purchase order contract to Revvity Health Sciences, Inc. to provide a P24 ELISA assay for HIV-1 testing. The contract has a ceiling value of $14,755.00 and a performance period ending on June 16, 2017. This contract award was not associated with a set-aside designation. Revvity Health Sciences, Inc. is a for-profit organization and...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract to Ai Biosciences, Inc., a minority-owned, self-certified small disadvantaged business, for the development of a low-cost, automated, and rapid home HIV viral load test. The award, which is part of the Small Business Innovation Research (SBIR) Program Phase I, has a potential value of $294,538.00 and a completion date of...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Advanced Cell Diagnostics, Inc. (ACD) on March 19, 2024. The $13,804.00 contract is for the delivery of ACD's RNAscope assay biological products, including kits, reagents, and probes, with a completion date of June 30, 2024. ACD is a for-profit manufacturer of diagnostic tools for personalized medicine applications and has...